We have entered into collaborations with academic institutions, pharmaceutical companies and biotechs that provide financial and other resources, including capabilities in research, development, manufacturing, and sales and marketing, to support our research and development programs. Several of our key collaborators are represented below:

Shire plc is Alba's partner for the development and commercialization of larazotide acetate (AT-1001) outside of the US and Japan.

Peptisyntha is Alba’s supply partner for production of therapeutic peptides (API).

The University of Maryland School of Medicine’s Mucosal Biology Research Center is Alba’s research partner and licensor of key intellectual property rights.